Evidence map›Paper›PMID 35055171›Full record

ArticleInternational journal of molecular sciences2022

Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation.

Youssef Khalil, Sara Carrino, Fujun Lin, Anna Ferlin, Heena V Lad, Francesca Mazzacuva, Sara Falcone, Natalie Rivers, Gareth Banks, Danilo Concas and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Youssef KhalilGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.ORCID 0000-0001-9025-3017
Sara CarrinoGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.ORCID 0000-0003-0398-6808
Fujun LinDepartment of Renal Medicine, University College London, London NW3 2PF, UK.ORCID 0000-0002-1887-545X
Anna FerlinDepartment of Renal Medicine, University College London, London NW3 2PF, UK.ORCID 0000-0002-1323-3634
Heena V LadMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Francesca MazzacuvaGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Sara FalconeMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.ORCID 0000-0002-8125-1121
Natalie RiversMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Gareth BanksMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Danilo ConcasMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Carlos AguilarMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Andrew R HaynesMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Andy BleaseMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Thomas NicolMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Raya Al-ShawiGenetics Unit and Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London NW3 2PF, UK.
Wendy HeywoodGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Paul PotterMRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK.
Kevin MillsGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Daniel P GaleDepartment of Renal Medicine, University College London, London NW3 2PF, UK.
Peter T ClaytonGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.ORCID 0000-0001-7592-4302
Mary Lyon Centre at MRC Harwell · GBGreat Ormond Street Hospital · GBUniversity College London · GBRoyal Brompton Hospital · GBShanghai Jiao Tong University · CNUniversity of East London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisomal fatty acid α-oxidation is an essential pathway for the degradation of β-carbon methylated fatty acids such as phytanic acid. One enzyme in this pathway is 2-hydroxyacyl CoA lyase (HACL1), which is responsible for the cleavage of 2-hydroxyphytanoyl-CoA into pristanal and formyl-CoA. Hacl1 deficient mice do not present with a severe phenotype, unlike mice deficient in other α-oxidation enzymes such as phytanoyl-CoA hydroxylase deficiency (Refsum disease) in which neuropathy and ataxia are present. Tissues from wild-type and

Indexed as

AnimalsBrainCarbon-Carbon LyasesCytochrome P450 Family 2Cytochrome P450 Family 4Fatty AcidsFemaleGene Knockout TechniquesKidneyLipidomicsLiverMaleMiceOxidation-ReductionPeroxisomesPhytanic Acid2-hydroxyphytanic acidCarbon-Carbon LyasesCytochrome P450 Family 2Cytochrome P450 Family 4Fatty AcidsHacl1 protein, mousemargaric acidPhytanic AcidPhytolisoprenoidsliverperoxisomesPPARsproteomics

Identifiers

PMID35055171
PMCPMC8781152
OpenAlexW4205340281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.